128 related articles for article (PubMed ID: 30371535)
1. Wilms Tumor Associated With the 9q22.3 Microdeletion Syndrome: 2 New Case Reports and a Review of The Literature.
Cayrol J; Nightingale M; Challis J; Campbell M; Sullivan M; Heloury Y
J Pediatr Hematol Oncol; 2019 Nov; 41(8):e517-e520. PubMed ID: 30371535
[TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor in patients with 9q22.3 microdeletion syndrome suggests a role for PTCH1 in nephroblastomas.
Isidor B; Bourdeaut F; Lafon D; Plessis G; Lacaze E; Kannengiesser C; Rossignol S; Pichon O; Briand A; Martin-Coignard D; Piccione M; David A; Delattre O; Jeanpierre C; Sévenet N; Le Caignec C
Eur J Hum Genet; 2013 Jul; 21(7):784-7. PubMed ID: 23169491
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyosarcoma, Wilms tumor, and deletion of the patched gene in Gorlin syndrome.
Cajaiba MM; Bale AE; Alvarez-Franco M; McNamara J; Reyes-Múgica M
Nat Clin Pract Oncol; 2006 Oct; 3(10):575-80. PubMed ID: 17019435
[TBL] [Abstract][Full Text] [Related]
4. A familial case of overgrowth syndrome caused by a 9q22.3 microdeletion in a mother and daughter.
Yamada H; Shimura M; Takahashi H; Nara S; Morishima Y; Go S; Miyashita T; Numabe H; Kawashima H
Eur J Med Genet; 2020 May; 63(5):103872. PubMed ID: 32028043
[TBL] [Abstract][Full Text] [Related]
5. Multiple tumor types including leiomyoma and Wilms tumor in a patient with Gorlin syndrome due to 9q22.3 microdeletion encompassing the PTCH1 and FANC-C loci.
Garavelli L; Piemontese MR; Cavazza A; Rosato S; Wischmeijer A; Gelmini C; Albertini E; Albertini G; Forzano F; Franchi F; Carella M; Zelante L; Superti-Furga A
Am J Med Genet A; 2013 Nov; 161A(11):2894-901. PubMed ID: 24124115
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of 9q22.3 microdeletion syndrome in utero following identification of craniosynostosis, overgrowth, and skeletal anomalies.
Reichert SC; Zelley K; Nichols KE; Eberhard M; Zackai EH; Martinez-Poyer J
Am J Med Genet A; 2015 Apr; 167A(4):862-5. PubMed ID: 25706929
[TBL] [Abstract][Full Text] [Related]
7. Further delineation of 9q22 deletion syndrome associated with basal cell nevus (Gorlin) syndrome: report of two cases and review of the literature.
Yamamoto K; Yoshihashi H; Furuya N; Adachi M; Ito S; Tanaka Y; Masuno M; Chiyo H; Kurosawa K
Congenit Anom (Kyoto); 2009 Mar; 49(1):8-14. PubMed ID: 19243411
[TBL] [Abstract][Full Text] [Related]
8. Early detection of chromosome 9q22.32q31.1 microdeletion and the nevoid basal cell carcinoma syndrome.
de Ravel TJ; Ameye L; Ballon K; Borghgraef M; Vermeesch JR; Devriendt K
Eur J Med Genet; 2009; 52(2-3):145-7. PubMed ID: 19233320
[TBL] [Abstract][Full Text] [Related]
9. The impact of tumor histology on treatment and prognosis of pediatric neoplasms.
Beckwith JB
Semin Pediatr Surg; 1993 Feb; 2(1):11-8. PubMed ID: 8062017
[No Abstract] [Full Text] [Related]
10. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
11. Microdeletion of 9q22.3: A patient with minimal deletion size associated with a severe phenotype.
Ewing AD; Cheetham SW; McGill JJ; Sharkey M; Walker R; West JA; West MJ; Summers KM
Am J Med Genet A; 2021 Jul; 185(7):2070-2083. PubMed ID: 33960642
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomic hybridization analysis of hepatoblastomas: additional evidence for a genetic link with Wilms tumor and rhabdomyosarcoma.
Steenman M; Tomlinson G; Westerveld A; Mannens M
Cytogenet Cell Genet; 1999; 86(2):157-61. PubMed ID: 10545709
[TBL] [Abstract][Full Text] [Related]
13. Gorlin syndrome patient with large deletion in 9q22.32-q22.33 detected by quantitative multiplex fluorescent PCR.
Musani V; Cretnik M; Situm M; Basta-Juzbasic A; Levanat S
Dermatology; 2009; 219(2):111-8. PubMed ID: 19439922
[TBL] [Abstract][Full Text] [Related]
14. A nude mouse Wilms' tumor line (KCMC-WT-1) derived from an aniridia patient with monoalleleic partial deletion of chromosome 11p.
Nagashima Y; Nishihira H; Miyagi Y; Tanaka Y; Sasaki Y; Nishi T; Imaizumi K; Aoki I; Misugi K
Cancer; 1996 Feb; 77(4):799-804. PubMed ID: 8616775
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of microdeletion 9q22.3 (pat).
Shimojima K; Adachi M; Tanaka M; Tanaka Y; Kurosawa K; Yamamoto T
Clin Genet; 2009 Apr; 75(4):384-93. PubMed ID: 19320658
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Wilms' tumours in monozygotic twins. Case report and review of the literature.
Svane S
Scand J Urol Nephrol; 1997 Jun; 31(3):297-8. PubMed ID: 9249897
[TBL] [Abstract][Full Text] [Related]
17. Bilateral Wilms' tumor.
Kullendorff CM; Wiebe T
Pediatr Surg Int; 1999; 15(1):46-9. PubMed ID: 9914355
[TBL] [Abstract][Full Text] [Related]
18. Hyperdiploidy in a case of favorable histology Wilms tumor.
Sandoval C; Ozkaynak MF; Tugal O; Jayabose S
Cancer Genet Cytogenet; 2001 May; 127(1):89-90. PubMed ID: 11408075
[TBL] [Abstract][Full Text] [Related]
19. Interstitial 9q22.3 microdeletion: clinical and molecular characterisation of a newly recognised overgrowth syndrome.
Redon R; Baujat G; Sanlaville D; Le Merrer M; Vekemans M; Munnich A; Carter NP; Cormier-Daire V; Colleaux L
Eur J Hum Genet; 2006 Jun; 14(6):759-67. PubMed ID: 16570072
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
